|
MechanismAT III activators |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.ES |
First Approval Date19 Dec 2001 |
100 Clinical Results associated with Pan Química Farmacéutica SA
0 Patents (Medical) associated with Pan Química Farmacéutica SA
100 Deals associated with Pan Química Farmacéutica SA
100 Translational Medicine associated with Pan Química Farmacéutica SA